Conversely, inhibiting FAO by etomoxir significantly impaired the proliferation (Fig. S5A–S5C) and metastasis (Fig. S5D and S5E) of CRC cells promoted by SLC44A2 knockdown. This evidence concerns the gene SLC44A2 and colorectal carcinoma.